ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979

NCCS Networker Volume 1 Issue 2, Summer 1987

June 13, 1987

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999